| Literature DB >> 31197846 |
Megan M Gessel1, Jeffrey M Spraggins2,3,4, Paul A Voziyan1,5, Dale R Abrahamson6, Richard M Caprioli2,3,7, Billy G Hudson1,3,5,7.
Abstract
Alport syndrome is caused by mutations in collagen IV that alter the morphology of renal glomerular basement membrane. Mutations result in proteinuria, tubulointerstitial fibrosis, and renal failure but the pathogenic mechanisms are not fully understood. Using imaging mass spectrometry, we aimed to determine whether the spatial and/or temporal patterns of renal lipids are perturbed during the development of Alport syndrome in the mouse model. Our results show that most sulfatides are present at similar levels in both the wild-type (WT) and the Alport kidneys, with the exception of two specific sulfatide species, SulfoHex-Cer(d18:2/24:0) and SulfoHex-Cer(d18:2/16:0). In the Alport but not in WT kidneys, the levels of these species mirror the previously described abnormal laminin expression in Alport syndrome. The presence of these sulfatides in renal tubules but not in glomeruli suggests that this specific aberrant lipid pattern may be related to the development of tubulointerstitial fibrosis in Alport disease.Entities:
Keywords: Alport syndrome; Basement membrane; Imaging mass spectrometry; Kidney; Lipid; Sulfatide
Mesh:
Substances:
Year: 2019 PMID: 31197846 PMCID: PMC6655412 DOI: 10.1002/lipd.12171
Source DB: PubMed Journal: Lipids ISSN: 0024-4201 Impact factor: 1.880